Pacific Biosciences Of California (PACB) Change in Inventory (2011 - 2026)

Pacific Biosciences Of California has reported Change in Inventory for 16 years, with the latest figure at $11.3 million in Q2 2026.

• On a quarterly basis, Change in Inventory rose 746.69% year-over-year to $11.3 million in Q2 2026; TTM through Jun 2026 was $12.0 million, a 362.46% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, down 82.94% from the prior year.
• Change in Inventory was $11.3 million for Q2 2026 at Pacific Biosciences Of California, up from $3.2 million in the prior quarter.
• The five-year high for Change in Inventory was $13.3 million in Q1 2023, with the low at -$9.0 million in Q4 2023.
• Average Change in Inventory over 5 years is $4.0 million, with a median of $4.2 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2026: Change in Inventory tumbled 185.47% in 2023, then surged 746.69% in 2026.
• Over 5 years, Change in Inventory stood at $10.5 million in 2022, then sank by 185.47% to -$9.0 million in 2023, then rose by 21.47% to -$7.1 million in 2024, then soared by 50.42% to -$3.5 million in 2025, then soared by 421.1% to $11.3 million in 2026.
• The last three Change in Inventory figures came in at $11.3 million (Q2 2026), $3.2 million (Q1 2026), and -$3.5 million (Q4 2025), per Business Quant data.